Sea Crest Wealth Management, LLC Abbott Laboratories Transaction History

Sea Crest Wealth Management, LLC

$874 Million
Q2 2025

A detailed history of Sea Crest Wealth Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Sea Crest Wealth Management, LLC holds 11,996 shares of ABT stock, worth $1.54 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

11,996

Previous 14,185 15.43%

Holding current value

$1.54 Million

Previous $1.88 Million 13.29%

% of portfolio

0.19%

Previous 0.22%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 11, 2025	SELL	$123.95 - $138.08 $271,326 - $302,257	-2,189 Reduced 15.43%	11,996 $1.63 Million
Q1 2025 Apr 11, 2025	BUY	$111.1 - $140.22 $9,221 - $11,638	83 Added 0.59%	14,185 $1.88 Million
Q4 2024 Jan 14, 2025	BUY	$111.93 - $119.39 $10,969 - $11,700	98 Added 0.7%	14,102 $1.6 Million
Q3 2024 Oct 16, 2024	SELL	$100.07 - $118.13 $18,613 - $21,972	-186 Reduced 1.31%	14,004 $1.6 Million
Q2 2024 Jul 19, 2024	BUY	$100.73 - $112.44 $20,548 - $22,937	204 Added 1.46%	14,190 $1.47 Million
Q1 2024 Apr 18, 2024	SELL	$109.52 - $120.96 $136,680 - $150,958	-1,248 Reduced 8.19%	13,986 $1.59 Million
Q4 2023 Jan 18, 2024	SELL	$90.19 - $110.4 $26,966 - $33,009	-299 Reduced 1.92%	15,234 $1.68 Million
Q3 2023 Oct 12, 2023	SELL	$95.53 - $114.62 $31,715 - $38,053	-332 Reduced 2.09%	15,533 $1.5 Million
Q2 2023 Jul 14, 2023	BUY	$100.78 - $112.29 $15,923 - $17,741	158 Added 1.01%	15,865 $1.73 Million
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $23,052 - $27,134	238 Added 1.54%	15,707 $1.59 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $55,324 - $64,904	-582 Reduced 3.63%	15,469 $1.7 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $725,119 - $839,552	-7,494 Reduced 31.83%	16,051 $1.55 Million
Q2 2022 Aug 09, 2022	SELL	$102.07 - $123.37 $21,945 - $26,524	-215 Reduced 0.9%	23,545 $2.56 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $626,083 - $763,468	-5,491 Reduced 18.77%	23,760 $2.81 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $643,271 - $787,649	5,568 Added 23.51%	29,251 $4.12 Million
Q3 2021 Nov 16, 2021	BUY	$116.66 - $129.06 $300,516 - $332,458	2,576 Added 12.2%	23,683 $2.8 Million
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $19,359 - $22,788	-183 Reduced 0.86%	21,107 $2.45 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $10,557 - $12,438	97 Added 0.46%	21,290 $2.55 Million
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $123,795 - $134,901	1,179 Added 5.89%	21,193 $2.32 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $34,823 - $42,290	-380 Reduced 1.86%	20,014 $2.18 Million
Q2 2020 Jul 27, 2020	SELL	$76.57 - $98.0 $61,715 - $78,988	-806 Reduced 3.8%	20,394 $1.87 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $15,013 - $21,954	-239 Reduced 1.11%	21,200 $1.67 Million
Q4 2019 Jan 22, 2020	BUY	$78.51 - $87.4 $121,926 - $135,732	1,553 Added 7.81%	21,439 $1.86 Million
Q3 2019 Oct 15, 2019	BUY	$81.84 - $88.74 $51,886 - $56,261	634 Added 3.29%	19,886 $1.66 Million
Q2 2019 Jul 19, 2019	SELL	$72.88 - $85.0 $12,681 - $14,790	-174 Reduced 0.9%	19,252 $1.62 Million
Q1 2019 May 10, 2019	SELL	$66.22 - $80.06 $4,304 - $5,203	-65 Reduced 0.33%	19,426 $1.55 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $57,561 - $65,209	-878 Reduced 4.31%	19,491 $1.41 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $122,167 - $147,380	-2,009 Reduced 8.98%	20,369 $1.49 Million
Q2 2018 Aug 03, 2018	BUY	$57.57 - $63.54 $541,906 - $598,102	9,413 Added 72.6%	22,378 $1.37 Million
Q1 2018 Apr 20, 2018	BUY	$56.27 - $63.62 $35,112 - $39,698	624 Added 5.06%	12,965 $777,000
Q4 2017 Feb 02, 2018	BUY	$53.68 - $57.47 $662,464 - $709,237	12,341	12,341 $704,000

Others Institutions Holding ABT

# of Institutions

3,575

Shares Held

1.38B

Call Options Held

9.72M

Put Options Held

8.83M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $225B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.

Account

Sea Crest Wealth Management, LLC Abbott Laboratories Transaction History